Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean category antidepressive agent an group approved?
Displaying drugs 551 - 575 of 10466 in total

Remoxipride

Remoxipride is an atypical antipsychotic agent that is specific for dopamine D2 receptors. It gained approval in the UK in 1989 but was withdrawn in 1993 after it was found to be associated with an increased incidence of aplastic anemia.[A215422,A215512]
Approved
Withdrawn
Matched Description: … Remoxipride is an atypical antipsychotic agent that is specific for dopamine D2 receptors. ... gained approval in the UK in 1989 but was withdrawn in 1993 after it was found to be associated with an …
Matched Categories: … Antipsychotic Agents ... Dopamine Agents ... Neurotoxic agents ... Tranquilizing Agents ... Neurotransmitter Agents …

Ensulizole

Ensulizole, also known as 2-phenylbenzimidazole-5-sulfonic acid, is a water-soluble sunscreen agent that absorbs strongly at UV-B wavelengths. It is commonly found in cosmetic products and sunscreen formulas in combination with other UV filter compounds due to its minimal protection against UV-A wavelengths. Due to its water solubility, ensulizole is commonly...
Approved
Matched Description: … According to the FDA, the maximal approved concentration of ensulizole is 148 mM although concentrations …
Matched Categories: … Sunscreen Agents …

Tiagabine

Tiagabine is an anti-convulsive medication. It is also used in the treatment for panic disorder as are a few other anticonvulsants. Though the exact mechanism by which tiagabine exerts its effect on the human body is unknown, it does appear to operate as a selective GABA reuptake inhibitor.
Approved
Investigational
Matched Description: … Tiagabine is an anti-convulsive medication. …
Matched Categories: … GABA Agents ... Neurotransmitter Agents ... Central Nervous System Agents …

Polyethylene glycol

Polyethylene glycol (PEG) is a synthetic polymer produced via polymerization of ethylene oxide molecules to make joining units of ethylene glycol by an ether linkage.[A190975,A190978] PEGs are water-soluble polymers that can form hydrogen bonds in a ratio of 100 water molecules per one PEG molecule. Molecular weights of PEGs vary...
Approved
Vet approved
Matched Description: … produced via polymerization of ethylene oxide molecules to make joining units of ethylene glycol by an …
Matched Categories: … Pegylated agents ... Gastrointestinal Agents ... Surface-Active Agents …

Hydralazine

Originally developed in the 1950s as a malaria treatment, hydralazine showed antihypertensive ability and was soon repurposed. Hydralazine is a hydrazine derivative vasodilator used alone or as adjunct therapy in the treatment of hypertension and only as adjunct therapy in the treatment of heart failure.[A186820,L8782,L8785] Hydralazine is no longer a...
Approved
Matched Description: … [T691] Hydralazine hydrochloride was FDA approved on 15 January 1953.[L8779] …
Matched Categories: … Antihypertensive Agents ... Cardiovascular Agents ... Hypotensive Agents ... Vasodilating Agents ... Arteriolar Smooth Muscle, Agents Acting On …

Strontium ranelate

Strontium ranelate, a strontium (II) salt of ranelic acid, is a medication for osteoporosis. Some reports have shown that strontium ranelate can slow down the progression of osteoarthritis of the knee. This agent presents an atypical mechanism of action in which it increases deposition of new bone by osteoblasts and,...
Approved
Withdrawn
Matched Description: … ) 2 g granules for oral suspension by Servier, it was ultimately discontinued in 2016-2017 owing to an ... This agent presents an atypical mechanism of action in which it increases deposition of new bone by osteoblasts …
Matched Categories: … Bone Density Conservation Agents …

Propofol

Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness,...
Approved
Investigational
Vet approved
Matched Description: … Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia …
Matched Categories: … Hypotensive Agents ... Agents Causing Muscle Toxicity ... QTc Prolonging Agents ... Agents that produce hypertension ... Central Nervous System Agents …

Guanfacine

Guanfacine, or BS 100-141,[A189838,A189841] is a selective alpha-A2 adrenergic receptor agonist initially indicated for the treatment of hypertension but is now indicated as an extended release tablet for the treatment of ADHD. Guanfacine was first described in the literature in 1974. Guanfacine was granted FDA approval on 27 October 1986.
Approved
Investigational
Matched Description: … receptor agonist initially indicated for the treatment of hypertension[L11274] but is now indicated as an …
Matched Categories: … Adrenergic Agents ... Hypotensive Agents ... Cardiovascular Agents ... Antihypertensive Agents ... Agents producing tachycardia …

Apronalide

Apronalide is approved in Japan. Apronalide has been withdrawn from the market in many other countries due to patient development of thrombocytopenic purpura .
Approved
Matched Description: … Apronalide is approved in Japan. …

Beremagene geperpavec

Beremagene geperpavec is a live, replication-defective herpes simplex virus type 1 (HSV-1)-based vector therapy. Developed by Krystal Biotech, it was first approved by the FDA on May 19, 2023, for the treatment of wounds associated with dystrophic epidermolysis bullosa (DEB). DEB is caused by mutations in the COL7A1 gene that...
Approved
Matched Description: … Developed by Krystal Biotech, it was first approved by the FDA on May 19, 2023, for the treatment of …

Influenza A virus A/Texas/50/2012 X-223A (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Description: … from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an …

Betaxolol

A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
Approved
Investigational
Matched Categories: … Adrenergic Agents ... Autonomic Agents ... Antiarrhythmic agents ... Hypotensive Agents ... Cardiovascular Agents …

Morphine

Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805. It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse. Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength...
Approved
Investigational
Matched Categories: … Hypotensive Agents ... Sensory System Agents ... Central Nervous System Agents ... Peripheral Nervous System Agents …

Trichlormethiazide

A thiazide diuretic with properties similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p830)
Approved
Vet approved
Matched Categories: … Antihypertensive Agents ... Cardiovascular Agents ... Natriuretic Agents ... Hyperglycemia-Associated Agents ... trichlormethiazide and potassium-sparing agents …

Bacillus calmette-guerin substrain tice live antigen

Bacillus calmette-guerin substrain tice live antigen is a vaccine containing attenuated live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis for percutaneous use. It is administered to prevent the development of tuberculosis.
Approved

Von Willebrand factor human

The human von Willebrand factor (vWF) is a human plasma-derived vWF, an endogenous large multimeric plasma glycoprotein involved in hemostasis. It serves a dual role in hemostasis by mediating platelet adhesion and aggregation at the site of blood vessel injury and stabilizing procoagulant factor VIII (FVIII). Exogenous sources of vWF...
Approved
Investigational
Matched Description: … It was first approved by the FDA in 2015. ... The human von Willebrand factor (vWF) is a human plasma-derived vWF, an endogenous large multimeric plasma …

Bepotastine

Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. Bepotastine was approved in Japan for use in the treatment of allergic rhinitis and uriticaria/puritus in July 2000 and January 2002, respectively, and is marketed by Tanabe Seiyaku Co., Ltd. under the brand name Talion. It is available...
Approved
Matched Description: … The opthalmic solution is FDA approved since Sept 8, 2009 and is under the brand name Bepreve. ... Bepotastine was approved in Japan for use in the treatment of allergic rhinitis and uriticaria/puritus …
Matched Categories: … Anti-Allergic Agents …

Ripretinib

Ripretinib is a kinase inhibitor used for the treatment of advanced gastrointestinal stromal tumor (GIST) that has not adequately responded to other kinase inhibitors such as sunitinib and imatinib. Ripretinib, also known as Qinlock, is manufactured by Deciphera Pharmaceuticals and was initially approved by the FDA on May 15, 2020....
Approved
Matched Description: … [L13769] It is the first drug approved as a fourth-line therapy in the specific setting of prior ... Ripretinib, also known as Qinlock, is manufactured by Deciphera Pharmaceuticals and was initially approved …
Matched Categories: … Antineoplastic Agents ... Antineoplastic and Immunomodulating Agents …

Alfuzosin

Benign prostatic hyperplasia (BPH) refers to a benign growth or hyperplasia of the prostate and leads to lower urinary tract symptoms in men, such as urgency, frequency and changes to urine flow. The prevalence of BPH is as high as 50%-60% for males in their 60's, and this prevalence increases...
Approved
Investigational
Matched Description: … [A228483] Alfuzosin is an alpha-1 adrenergic blocker used in the symptomatic treatment of BPH that works ... [L31593] It was initially approved by the FDA in 2003 and is marketed by several pharmaceutical companies …
Matched Categories: … Adrenergic Agents ... Urological Agents ... Genitourinary Agents ... QTc Prolonging Agents ... Neurotransmitter Agents …

Oritavancin

Oritavancin is a glycopeptide antibiotic used for the treatment of skin infections. It was developed by The Medicines Company (acquired by Novartis). Oritavancin was initially approved by the FDA in 2014 and formulated to combat susceptible gram-positive bacteria that cause skin and skin structure infections. It boasts the option of...
Approved
Investigational
Matched Description: … [A39384,A193482,L8492] On March 12, 2021 the FDA approved Kimyrsa, a complete course of therapy in ... [L32634] Orbactiv, the other FDA approved oritavancin product, is administered over a 3 hour infusion ... [L12858] Oritavancin was initially approved by the FDA in 2014 and formulated to combat susceptible gram-positive …
Matched Categories: … Anti-Bacterial Agents ... Anti-Infective Agents …

Phenoxyethanol

Phenoxyethanol is a colorless liquid with a pleasant odor. It is a glycol ether used as a perfume fixative, insect repellent, antiseptic, solvent, preservative, and also as an anesthetic in fish aquaculture. Phenoxyethanol is an ether alcohol with aromatic properties. It is both naturally found and manufactured synthetically. Demonstrating antimicrobial...
Approved
Matched Description: … Phenoxyethanol (EU), or PE, is the most commonly used globally-approved preservative in personal care ... Phenoxyethanol is an ether alcohol with aromatic properties. ... ether used as a perfume fixative, insect repellent, antiseptic, solvent, preservative, and also as an …
Matched Categories: … Anti-Infective Agents ... Anti-Infective Agents, Local ... Central Nervous System Agents …

Mirikizumab

Mirikizumab is a monoclonal antibody developed by Eli Lilly intended to treat ulcerative colitis. It inhibits the actions of interleukin-23 (IL-23), a pro-inflammatory cytokine that activates pathways contributing to the development of inflammatory diseases.[L46237,L46257] Mirikizumab is approved in Japan and received a positive opinion from the EMA's Committee for Medicinal...
Approved
Investigational
Matched Description: … [L46237,L46257] Mirikizumab is approved in Japan[L46252] and received a positive opinion from the ... [L46252] It was officially approved in the EU in May 2023[L48656] and Canada in July 2023[L48661], and ... was eventually approved in the US in October 2023[L48651] for the treatment of adult patients with moderate-to-severely …
Matched Categories: … Anti-Ulcer Agents ... Antirheumatic Agents ... Anti-Inflammatory Agents ... Gastrointestinal Agents ... Immunosuppressive Agents …

Clobazam

Clobazam belongs to the 1,5-benzodiazepine class of drugs and is marketed under different names, Onfi, Frisium, Urbanyl, and others. . Clobazam was first synthesized in 1966 and first published in 1969, following the incidental synthesis and discovery of the first benzodiazepine chlordiazepoxide in the 1950s. Unlike older 1,4-benzodiazepines, clobazam has...
Approved
Illicit
Matched Description: … [A521,A522] In October 21, 2011, the FDA approved clobazam as an adjunctive treatment for seizures associated ... [A256968,A256973] Clobazam has been marketed as an anxiolytic since 1975 and an anticonvulsant since ... [A256958] In 2005, clobazam also received approval from Health Canada as an add-on therapy for generalized …
Matched Categories: … Anti-Anxiety Agents ... GABA Agents ... Tranquilizing Agents ... Central Nervous System Agents ... Neurotransmitter Agents …

Drometrizole trisiloxane

Drometrizole trisiloxane is a photostable UVA and UVB light filter [A33069, L2780, L2781, L2782, L2783, F81]. The compound is a lipophilic benzotriazole derivative marketed as Meroxyl XL by L'Oreal, although sunscreens with drometrizole trisiloxane are currently only approved for use in the EU, Canada, Australia, and Japan, among other countries....
Approved
Matched Description: … marketed as Meroxyl XL by L'Oreal, although sunscreens with drometrizole trisiloxane are currently only approved …

Tivozanib

Renal cell carcinoma (RCC) is responsible for 3% of cancer cases and is one of the 10 most common cancers in adults. The average age of diagnosis is between age 65 to 74. Tivozanib, also known as FOTIVDA, is a kinase inhibitor developed to treat adult patients with relapsed or...
Approved
Investigational
Matched Description: … It was approved on March 10, 2021 by the FDA. …
Matched Categories: … Antineoplastic Agents ... Antineoplastic and Immunomodulating Agents …
Displaying drugs 551 - 575 of 10466 in total